BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1903362)

  • 1. [Therapy of osteoporosis using the ADFR schedule (especially with parathyroid hormone and etidronate)].
    Ziegler R
    Internist (Berl); 1991 Feb; 32(2):76-9. PubMed ID: 1903362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated according to the ADFR (activation, depression of resorption, formation, repeat the cycle) with parathyroid hormone and diphosphonates (Hannover PTH I study)].
    Delling G; Dreyer T; Hahn M; Vogel M; Rittinghaus EF; Hesch RD
    Z Orthop Ihre Grenzgeb; 1990; 128(1):1-5. PubMed ID: 2138378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is reliable in therapy of osteoporosis?].
    Ziegler R
    Internist (Berl); 1990 Nov; 31(11):680-8. PubMed ID: 2289853
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1-38 hPTH) and sequential addition of calcitonin nasal spray].
    Vogel M; Hesch RD; Delling G
    Med Klin (Munich); 1990 Feb; 85(2):82-6. PubMed ID: 2319988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination and sequential therapy with PTH and bisphosphonates.
    Bauer DC
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):407. PubMed ID: 15758282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Early therapy of osteoporosis with (1-38) parathyroid hormone and calcitonin nasal spray].
    Hesch RD; Rittinghaus EF; Harms HM; Delling G
    Med Klin (Munich); 1989 Oct; 84(10):488-98. PubMed ID: 2685534
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of osteoporosis with fluorides and calcitonins].
    Ringe JD
    Internist (Berl); 1991 Feb; 32(2):80-9. PubMed ID: 2032792
    [No Abstract]   [Full Text] [Related]  

  • 10. [Etidronate and calcitonin to PTH (1-84) in postmenopausal osteoporosis].
    Rodríguez Rodríguez LP
    An R Acad Nac Med (Madr); 2011; 128(1):169-91; discussion 191-8. PubMed ID: 23350342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis.
    Thomas T; Lafage MH; Alexandre C
    J Rheumatol; 1995 Nov; 22(11):2183-5. PubMed ID: 8596168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management of osteoporosis.
    Mulloy AL; Weinstein RS
    J Med Assoc Ga; 1994 Apr; 83(4):227-30. PubMed ID: 8006552
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of combination regimens for osteoporosis--prevention and treatment.
    Miller E; Kalin MF
    Int J Fertil Womens Med; 2002; 47(5):198-204. PubMed ID: 12469706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronate.
    Mallette LE; LeBlanc AD; Pool JL; Mechanick JI
    J Bone Miner Res; 1989 Apr; 4(2):143-8. PubMed ID: 2499164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FPIN's clinical inquiries. Combination therapy for postmenopausal osteoporosis.
    Howard E; Tagliarino-Jones H
    Am Fam Physician; 2010 Feb; 81(4):439. PubMed ID: 20148496
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment and an ADFR regime.
    Steiniche T; Hasling C; Charles P; Eriksen EF; Melsen F; Mosekilde L
    Bone; 1991; 12(3):155-63. PubMed ID: 1910957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2002 Nov; 1(3):13-8. PubMed ID: 15529101
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination and sequential therapy for osteoporosis.
    Heaney RP; Recker RR
    N Engl J Med; 2005 Aug; 353(6):624-5. PubMed ID: 16093472
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis.
    Hasling C; Charles P; Jensen FT; Mosekilde L
    Osteoporos Int; 1994 Jul; 4(4):191-203. PubMed ID: 7949749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoporosis therapy. Bisphosphonates compared].
    MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.